Skandinaviska Enskilda Banken AB publ Sells 343,908 Shares of Colgate-Palmolive (NYSE:CL)

Skandinaviska Enskilda Banken AB publ lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 14.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,067,910 shares of the company’s stock after selling 343,908 shares during the period. Colgate-Palmolive makes up about 0.8% of Skandinaviska Enskilda Banken AB publ’s portfolio, making the stock its 19th largest holding. Skandinaviska Enskilda Banken AB publ owned approximately 0.25% of Colgate-Palmolive worth $187,746,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in CL. FMR LLC raised its stake in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. AMF Tjanstepension AB grew its holdings in shares of Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after purchasing an additional 2,353,268 shares during the last quarter. Barclays PLC increased its position in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. State Street Corp lifted its stake in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Colgate-Palmolive in the 4th quarter valued at approximately $132,405,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 3.6 %

NYSE:CL opened at $90.71 on Thursday. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $73.61 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The firm has a fifty day simple moving average of $89.03 and a two-hundred day simple moving average of $94.96.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm posted $0.87 earnings per share. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Raymond James reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.